Category: Pharmaceuticals
Africa Pharmaceuticals
-
Ghana Pharmaceuticals & Healthcare Q3 2019
... high operational costs for foreign companies. While Ghana is positioned as one of the more attractivepharmaceutical markets for multinational firms on a regional basis, generic products will maintain a dominant share of the market,somewhat limiting ... Read More
-
Mozambique Pharmaceuticals & Healthcare Q3 2019
... its value over the long term, given the country’s growing population, high disease burden and some efforts by thegovernment to improve overall healthcare. Nonetheless, Mozambique’s small pharmaceutical market will still remain one of theleast attractive ... Read More
-
Ethiopia Pharmaceuticals & Healthcare Q3 2019
... and healthcare markets will remain dependent on available finances andthe wider political and economic climate. Nevertheless, authorities are aiming to extend healthcare coverage and improve regionalservices, which is already attracting niche investment from Chinese companies. Read More
-
Mauritius Pharmaceuticals & Healthcare Q3 2019
... supportgrowing health spending. Pharmaceutical imports will continue to account for most of the market, given limited local drugmanufacturing capacity. The gradual strengthening of drug sale regulation will improve drug use safety and the operatingenvironment. Over ... Read More
-
Nigeria Pharmaceuticals & Healthcare Q3 2019
... despite it's elevatedrisk profile. Long-term opportunities are supported by robust fundamentals such as a large market size and expandingpopulation. The implementation of governmental initiatives aim to drive growth in the sector over the coming years. Read More
-
Tunisia Pharmaceuticals & Healthcare Q3 2019
... will challenge foreign investment into the sector. Highlightingthe market's long-term potential, some multinational drugmakers have shown their willingness to do business in the countryalthough the majority choose to operate indirectly to minimise the risks involved. Read More
-
Cote d'Ivoire Pharmaceuticals & Healthcare Q3 2019
... the country has issue with counterfeit drugs and a weak regulatory environment. On a positive note, the gradual roll-out ofuniversal healthcare coverage scheme will promote market stability, though this will not translate into major commercialopportunities. Read More
-
Kenya Pharmaceuticals & Healthcare Q3 2019
... boosted factors such as the risingpopulation numbers, which recently surpassed 50 million, the pending rollout of universal health coverage, high technologicalliteracy of its people and the prevalent disease profile. However, the lacking healthcare financing and ... Read More
-
South Africa Pharmaceuticals & Healthcare Q3 2019
... the regulatoryenvironment, reformed intellectual property policy and the expansion of healthcare coverage through the implementation of theNational Health Insurance Scheme are ongoing tasks that if implemented successfully in the long term will further boost theattractiveness ... Read More
-
Zambia Pharmaceuticals & Healthcare Q3 2019
... and adequate healthcareand pharmaceutical services. The currency devaluation will further impact the affordability of medical supplies, given most of themare imported, and also provide fertile grounds for further uptake of the already prevalent counterfeit drugs. Read More
-
Egypt Pharmaceuticals & Healthcare Q3 2019
... unmet medical need, its lacking intellectual property (IP) and regulatorysystems continue to deter investment and the interest of innovative drugmakers. Additionally, the country’s restrictive drug pricingregime and the pound's flotation will continue to pose significant ... Read More
-
Angola Pharmaceuticals & Healthcare Q2 2019
... of patented medicines. Opportunities exist fordrugmakers willing to invest in an underdeveloped market with a high disease burden. However, a difficult business environment,weak regulations and low levels of affordability will ensure that the market will ... Read More
-
Generic Pharmaceutical Market in Kenya and Nigeria, Forecast to 2022
... a significant proportion of these disease areas are financed by global aid organizations that are also helping in poverty eradication in the continent. Parallelly, with each passing year, the incidence of non-communicable diseases has also ... Read More
-
Gabon Pharmaceuticals & Healthcare Q2 2019
... and the lack of public sector funding continue to hamper their commercial potential, despite thegradually rising demand. The growing population number and the increased incidence of civilisation diseases will still offer fewopportunities innovative medicines drugmakers. Read More
-
Sub-Saharan Africa Pharmaceuticals & Healthcare Q2 2019
... within the generic medicines sector, while the larger more developed marketspresent viable opportunities for patented medicine sales in urban regions. Cooperative agreements with international firms willprovide opportunities for domestic firms to expand their manufacturing capacities. Read More
-
Morocco Pharmaceuticals & Healthcare Q2 2019
... coverage and the country's growing non-communicable disease burden will provide significant tailwinds for future medicine sales. We believe generic drug makers will be themain beneficiaries as the state adopts a pro-generic stance and continues to ... Read More
-
Namibia Pharmaceuticals & Healthcare Q2 2019
... be involved in Namibia's market mostly through imports anddonations. While the business environment is relatively sound, the small overall market size and the lacking financial support forhealthcare and pharmaceutical sectors allow for few commercial opportunities. Read More
-
Tanzania Pharmaceuticals & Healthcare Q2 2019
... government recognises the need to secure the country'sessential medicine supply and implement various strategies to achieve this with restrictive finances. Efforts to develop a moreconducive business environment and stronger regulations combined with robust economic growth ... Read More
-
Free From in Egypt
... to be free from these ingredients. Such consumers will often only buy imported brands, distribution of which is largely limited to specialist outlets, or else avoid certain types of packaged food altogether in favour of ... Read More
-
Uganda Pharmaceuticals & Healthcare Q2 2019
... health services and medical supplies willremain a major challenge to Uganda's pharmaceutical market in the near term. The expected implementation of the AfricanContinental Free Trade Agreement will benefit Uganda’s healthcare market and pharmaceutical industry development. Read More
-
Pharmaceuticals in South Africa
... leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. The South ... Read More
-
Consumer Health in Nigeria
... demand for medicine in the country. In addition to the increased urban population, market size and product availability, stress and an unsafe environment have exposed people to health concerns. The consumer health market has therefore ... Read More
-
Cough, Cold and Allergy (Hay Fever) Remedies in Morocco
... a boost during the spring and winter seasons, especially in big cities where the pollution rate is high. Local consumers have become sensitive and developed weak immune systems. The humid weather and pollution are the ... Read More
-
Cough, Cold and Allergy (Hay Fever) Remedies in Nigeria
... Nigeria, as a result of the pollution encountered during people’s day-to-day activities, leading to them suffering more coughs, colds and allergies. As there are no current solutions to the reduction in air pollution, sales of ... Read More
-
Dermatologicals in Morocco
... of products marketed at various prices. Their availability is not limited to pharmacies and parapharmacies, as consumers can purchase them through internet retailing and even social media pages. Due to the changing lifestyle habits of ... Read More
Research Assistance
